HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  New England Journal of Medicine

• Publication date

  2011-03-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMoa1013297PMID 21428769PMCID PMC3113609
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiepileptic drugs and the immune system

  2011cited by this paper
• Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.

  2011cited by this paper
• Hla-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population.

  2011cited by this paper
• Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B*1502 in a Han Chinese population.

  2010cited by this paper
• Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.

  2010cited by this paper
• The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

  2010cited by this paper
• Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia

  2010cited by this paper
• Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.

  2010cited by this paper
• Acute generalized exanthematous pustulosis: an overview of the clinical, immunological and diagnostic concepts.

  2010cited by this paper
• MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes

  2010cited by this paper
• Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury.

  2010cited by this paper
• HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

  2009cited by this paper
• Estimation of high-resolution HLA-A, -B, -C, -DRB1 allele and haplotype frequencies based on 8862 German stem cell donors and implications for strategic donor registry planning.

  2009cited by this paper
• Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians.

  2009cited by this paper
• High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients

  2009cited by this paper
• Association of HLA-B*1502 allele and carbamazepine- induced severe adverse cutaneous drug reaction among Asians, a review

  2008cited by this paper
• High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients.

  2008cited by this paper
• Human leukocyte antigen genotypes in carbamazepine‐induced severe cutaneous adverse drug response in Japanese patients

  2008cited by this paper
• HLA-B*5701 screening for hypersensitivity to abacavir.

  2008cited by this paper
• Carbamazepine and phenytoin induced Stevens‐Johnson syndrome is associated with HLA‐B*1502 allele in Thai population

  2008cited by this paper
• Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations.

  2008cited by this paper
• Human leukocyte antigen-A, -B, and -DRB1 haplotypes of cord blood units in the Tzu Chi Taiwan Cord Blood Bank.

  2008cited by this paper
• The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV

  2008cited by this paper
• A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

  2008cited by this paper
• Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity.

  2007cited by this paper
• Variability in the clinical pattern of cutaneous side‐effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

  2007cited by this paper
• The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.

  2007cited by this paper
• PLINK: a tool set for whole-genome association and population-based linkage analyses.

  2007cited by this paper
• Prospective screening for human leukocyte antigen-B*5701 avoids abacavir hypersensitivity reaction in the ethnically mixed French HIV population.

  2007cited by this paper
• Association between HLA‐B*1502 Allele and Antiepileptic Drug‐Induced Cutaneous Reactions in Han Chinese

  2007cited by this paper
• A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC

  2006influential reference
• Medical Genetics: A Marker for Stevens-Johnson SyndromeChung W-H, Hung S-I, Hong H-S, et al (Chang Gung Mem Hosp, Taipei, Taiwan; Inst of Biomedical Sciences, Taipei, Taiwan) Nature 428:486, 2004§

  2006cited by this paper
• A marker for Stevens-Johnson syndrome …: ethnicity matters

  2006cited by this paper
• HLA-B locus in Caucasian patients with carbamazepine hypersensitivity.

  2006cited by this paper
• Variability in the clinical pattern of cutaneous side‐effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

  2006cited by this paper
• Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions

  2006cited by this paper
• Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster

  2006cited by this paper
• Haploview: analysis and visualization of LD and haplotype maps

  2005cited by this paper
• Clinical heterogeneity of drug hypersensitivity.

  2005cited by this paper
• Carbamazepine‐induced acute liver failure as part of the DRESS syndrome

  2005cited by this paper
• MRI of segmental zoster paresis

  2005cited by this paper
• The immunological and clinical spectrum of delayed drug-induced exanthems

  2004influential reference
• Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity.

  2004cited by this paper
• Genetic variations in HLA-B region and hypersensitivity reactions to abacavir.

  2002cited by this paper
• Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.

  2002cited by this paper
• Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.

  2002cited by this paper
• T-cell involvement in drug-induced acute generalized exanthematous pustulosis.

  2001cited by this paper
• TNFα promoter region gene polymorphisms in carbamazepine-hypersensitive patients

  2001cited by this paper
• Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions.

  1999cited by this paper
• A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities

  1996cited by this paper
• Genome-wide association study identifies HLA-A ∗ 3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population

  year unknowncited by this paper

• An integrative neurogenomics workflow for precision medicine in neurodegenerative disorders.

  2026cites this paper
• Intrapatient variation in PD-L1 expression and tumor mutational burden and implications for outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer

  2026cites this paper
• Genetic susceptibility to heat identifies rare neurological diseases at particular risk from climate change impacts

  2026cites this paper
• Collagen II hydrogel-mediated sustained delivery of lacosamide attenuates cartilage degeneration and pain in osteoarthritis.

  2026cites this paper
• Cost‐effectiveness analysis of pharmacogenetic‐guided antiseizure medication therapy based on the risk of HLA‐A*31:01 allele variants in Japan

  2025cites this paper
• The Prevalence of Stevens–Johnson Syndrome Complications due to Antiepileptic Drug Use: A Systematic Review and Meta-Analysis

  2025cites this paper
• Guidelines From the French‐Speaking Society for Histocompatibility and Immunogenetics (SFHI) for Harmonisation of HLA Genotyping in Autoimmune Diseases, Drug Hypersensitivity and Pharmacogenetics

  2025cites this paper
• Exploring the Pharmacogenomic Map of Croatia: PGx Clustering of 522-Patient Cohort Based on UMAP + HDBSCAN Algorithm

  2025cites this paper
• Genome sequencing of 35,024 predominantly African ancestry persons addresses gaps in genomics and healthcare

  2025cites this paper
• Risk Factors for Drug‐Induced Severe Cutaneous Adverse Reactions: A Real‐World Pharmacovigilance Analysis

  2025cites this paper
• Embedding Pharmacogenetics Into Clinical Practice to Improve Patient Outcomes

  2025cites this paper
• Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A 15-year Regional Burn Center Experience

  2025cites this paper
• Adverse effects of antiseizure medications: a review of the impact of pharmacogenetics and drugs interactions in clinical practice

  2025cites this paper
• Clinical diagnosis and management of drug reaction with eosinophilia and systemic symptoms (DRESS) in children: An EAACI position paper

  2025cites this paper
• A crash course in genomics for epilepsy clinicians.

  2025cites this paper
• [Case 1. Drug hypersensitivity syndrome or "drug reaction with eosinophilia and systemic symptoms"].

  2025cites this paper
• Chronic Adverse Drug Reactions of Phenytoin: A Comprehensive Review

  2025cites this paper
• Advancing drug safety in psychiatry: insights from pharmacogenomics of hypersensitivity reactions

  2025cites this paper
• Exploring the link between carbamazepine- and lamotrigine-induced skin reactions and the HLA-A31:01 and HLA-B*1502 genetic markers

  2025cites this paper
• A comprehensive update on the human leukocyte antigen and idiosyncratic adverse drug reactions

  2025cites this paper
• Attribution of Causality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.

  2025cites this paper
• Erupción aguda diseminada

  2025cites this paper
• Enhancing Large-Scale Pharmacogenetic Studies in African Populations for Clinical Care and Drug Development.

  2025cites this paper
• Genomics of Bipolar Disorder: What the Clinician Needs to Know.

  2025cites this paper
• Syndrome de Lyell récidivant : Rapport de cas d'une patiente présentant deux épisodes successifs induits par l'allopurinol puis la ceftriaxone

  2025cites this paper
• One Man’s Meat Is Another Man’s Poison: High Incidence of Severe Cutaneous Drug Reactions Induced by Enfortumab Vedotin

  2025cites this paper
• Molecular docking to investigate HLA-associated idiosyncratic drug reactions

  2025cites this paper
• Drug Allergy Mimics.

  2024cites this paper
• HLA-DPB1*05:01 and HLA-A*11:01 Is Associated with Adverse Drug Reactions to Isoniazid and Rifampin for Treatment of Latent Tuberculosis Infection in South Korea

  2024cites this paper
• Understanding clozapine-related blood dyscrasias. Developments, genetics, ethnicity and disparity: it's a CIN

  2024cites this paper
• Interdisciplinary strategies for diagnosis and treatment of trigeminal neuralgia.

  2024influential citation
• Psychotropic Medications and Dermatological Side Effects: An In-Depth Review

  2024cites this paper
• Characterizing the genetic architecture of drug response using gene-context interaction methods

  2024cites this paper
• Éruption aiguë disséminée

  2024cites this paper
• Carbamazepine-induced Stevens-Johnson Syndrome: A Case Report with Review of the Literature.

  2024cites this paper
• Pharmacogenomics predictors of aromatic antiepileptic drugs-induced SCARs in the Iraqi patients

  2024cites this paper
• HLA-Related Drug Hypersensitivity Reactions

  2024cites this paper
• Risk factors for drug hypersensitivity reactions in children

  2024cites this paper
• Anti-tubercular therapy-induced maculopapular exanthema – A case series

  2024cites this paper
• Pharmacogenomic landscape of the Thai population from genome sequencing of 949 individuals

  2024cites this paper
• Stevens–Johnson syndrome and toxic epidermal necrolysis: Updates in pathophysiology and management

  2024cites this paper
• Stevens-Johnson syndrome/toxic epidermal necrolysis induced by lamotrigine in a patient with a cerebral cavernous malformation: a case report

  2024cites this paper
• Drug-induced lung disease: a narrative review

  2024cites this paper
• Human Leukocyte Antigens and Sulfamethoxazole/Cotrimoxazole-Induced Severe Cutaneous Adverse Reactions: A Systematic Review and Meta-Analysis.

  2024cites this paper
• Precision medicine engaging nucleoside analogues: New advances to a conventional arsenal

  2024cites this paper
• Severe cutaneous adverse reactions

  2024cites this paper
• Update on HLA-B*15:02 allele associated with adverse drug reactions.

  2024cites this paper
• Phenomic landscape and pharmacogenomic implications for HLA region in a Taiwan Han Chinese population

  2024cites this paper
• Toxic epidermal necrolysis caused by phenobarbital: a case report and literature review

  2024cites this paper
• [Carbamazepine induced Stevens-Johnson syndrome in Han Chinese with positive HLA-A * 3101 gene: A case report].

  2023cites this paper
• An association study of HLA with levofloxacin-induced severe cutaneous adverse drug reactions in Han Chinese

  2023influential citation
• Tools for Etiologic Diagnosis of Drug-Induced Allergic Conditions

  2023cites this paper
• How to assess pharmacogenomic tests for implementation in the NHS in England

  2023cites this paper
• Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review

  2023cites this paper
• Characterization of Drug-Specific CD4+ T-Cells Reveals Possible Roles of HLA Class II in the Pathogenesis of Carbamazepine Hypersensitivity Reactions

  2023cites this paper
• Non-adherence and epileptic emergency—reasons and solutions

  2023cites this paper
• HLA-B*57:01/Carbamazepine-10,11-Epoxide Association Triggers Upregulation of the NFκB and JAK/STAT Pathways

  2023influential citation
• New insights into the diagnosis and management of Stevens–Johnson syndrome and toxic epidermal necrolysis

  2023cites this paper
• Activation of human CD8+ T-cells with nitroso dapsone-modified HLA-B*13:01-binding peptides

  2023cites this paper
• Severe ocular complications of SJS/TEN and associations among pre-onset, acute, and chronic factors: a report from the international ophthalmology collaborative group

  2023cites this paper
• Personalized antiseizure medication therapy in critically ill adult patients

  2023cites this paper
• Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses

  2023cites this paper
• Pharmacogenomics: current status and future perspectives

  2023cites this paper
• Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions.

  2023cites this paper
• HLA alleles and antiseizure medication-induced cutaneous reactions in Brazil: A case-control study.

  2023cites this paper
• Seventy-five years of service: an overview of the College of American Pathologists’ proficiency testing program in histocompatibility and identity testing

  2023cites this paper
• Accurate identification of HLA-B*15:02 allele by two-dimensional polymerase chain reaction.

  2023cites this paper
• A blinded in vitro analysis of the intrinsic immunogenicity of hepatotoxic drugs: implications for preclinical risk assessment

  2023cites this paper
• A genetics-guided approach to the clinical management of schizophrenia.

  2023cites this paper
• Pharmacogenomic knowledge and awareness among diverse patients treated with angiotensin converting enzyme inhibitors.

  2023cites this paper
• An Overview on Adverse Drug Reactions (ADR) And Its Biomarkers

  2023cites this paper
• The BrainDrugs-epilepsy study: A prospective open-label cohort precision medicine study in epilepsy

  2023cites this paper
• Overview and Current Advances in Dapsone Hypersensitivity Syndrome

  2023cites this paper
• Cutaneous adverse drug reactions.

  2023cites this paper
• Delayed Drug Hypersensitivity Reactions: Molecular Recognition, Genetic Susceptibility, and Immune Mediators

  2023cites this paper
• Pharmacogenetics in Primary Headache Disorders

  2022influential citation
• Potential role of regulatory DNA variants in modifying the risk of severe cutaneous reactions induced by aromatic anti‐seizure medications

  2022cites this paper
• Drug-Induced Hypersensitivity Syndrome (DIHS)/ Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.

  2022cites this paper
• Adrenal suppression in patients with chronic obstructive pulmonary disease treated with glucocorticoids: Role of specific glucocorticoid receptor polymorphisms

  2022cites this paper
• Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.

  2022cites this paper
• Unique motif shared by HLA‐B*59:01 and HLA‐B*55:02 is associated with methazolamide‐induced Stevens–Johnson syndrome and toxic epidermal necrolysis in Han Chinese

  2022cites this paper
• The Immunogenetics of Cutaneous Drug Reactions.

  2022cites this paper
• Role of Pharmacogenomics in Reducing the Risk of Drug-Related Iatrogenesis

  2022cites this paper
• Association of HLA Alleles with Antiepileptic Drug-Induced Mild Cutaneous Reactions: A Case-Control Study of a Northeast Han Chinese Population.

  2022cites this paper
• DỊ ỨNG CARBAMAZEPINE VÀ MỐI LIÊN QUAN VỚI SỰ CÓ MẶT CỦA ALLELE HLA-B*15:02 VÀ HLA-A*31:01 TẠI BỆNH VIỆN TÂM ANH

  2022cites this paper
• Pharmacogenomics in Psychiatry Practice: The Value and the Challenges

  2022cites this paper
• Reacciones adversas medicamentosas cutáneas: enfoque en el servicio de urgencias

  2022cites this paper
• Role of human leukocyte antigen in anti-epileptic drugs-induced Stevens-Johnson Syndrome/toxic epidermal necrolysis: A meta-analysis.

  2022cites this paper
• Genetic markers of drug hypersensitivity in pediatrics: current state and promise

  2022cites this paper
• Genotyping for HLA risk alleles versus patch tests to diagnose anti-seizure medication induced cutaneous adverse drug reactions

  2022influential citation
• Rare Genetic Variation and Outcome of Surgery for Mesial Temporal Lobe Epilepsy

  2022cites this paper
• Acute Liver Injury in the setting of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome with Cocaine as suspected culprit agent: A case report.

  2022cites this paper
• Using human genetics to improve safety assessment of therapeutics

  2022cites this paper
• Advances in the Understanding of Drug Hypersensitivity: 2012 Through 2022.

  2022cites this paper
• Susceptibility Genes and HLA for Cold Medicine-Related SJS/TEN with SOC

  2022cites this paper
• Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)—Readdressing the DReSS

  2022cites this paper
• Genetische Biomarker von Schmerzzuständen

  2022cites this paper
• Avoidance of cutaneous adverse drug reactions induced by antiepileptic drugs based on pharmacogenomics

  2022cites this paper
• Exome sequencing allows detection of relevant pharmacogenetic variants in epileptic patients

  2022cites this paper
• An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical Practice

  2022cites this paper